March 21, 2016
Slightly higher open expected; RegMed sector, do you need a few stock trading clues?
March 18, 2016
Higher open expected; RegMed sector, quadruple witching, it’s still all about treading carefully
March 17, 2016
RegMed’s close: another dip on low volume and a reset to a positive close
March 14, 2016
Choppy open expected; RegMed sector, one negative close is followed by a positive close as the sequence repeats
March 10, 2016
RegMed’s close: any news or positives were sold into
March 7, 2016
Vericel (VCEL) FDA Accepts Filing of BLA for MACI for the Treatment of Symptomatic Cartilage defects in the Knee
March 4, 2016
RegMed’s close: up, up and almost away
March 3, 2016
RegMed’s close: the resistance levels are folding
March 2, 2016
RegMed’s close: a second up day
March 2, 2016
Lower open expected; RegMed sector, low volatility and volume compromise optimism
35 companies, 1 interpreter!
Insight, foresight and recommendation
My motto … never leave an investor uninformed! I say today what others won’t, so you can do what others can’t.
My name is Henry McCusker; I endorse these opinions under my own name and with a subscription based membership.
Do you have an opinion you would like to share with us? We would like to hear from you.
Please e-mail us at hwm@regmedinvestors.com.
Editor and Publisher ... Henry McCusker enters his tenth (10th) year at RegMed Investors
© 2026 RegMed Investors (regmedinvestors.com), all rights are reserved.
RegMed Investors (RMi) or Regmedinvestors.com content is the intellectual property of Henry McCusker. Any copying, republication or redistribution of RMI’s content, including by framing or similar means, is expressly prohibited without the prior written consent of Scimitar; who also shall not be liable for any errors or delays in content, or for any actions taken in reliance thereon. For additional information on other Scimitar media services or reposting please email hwm@regmedinvestors.com.
The information included above as well as individual companies and/or securities mentioned should be construed as guidance in RMi reviews.
The facts stated and the opinions given in this publication are based on data and information considered to be reliable and have been carefully worked into my qualitative analyses and prognoses. However, no guarantee can be given as to their fairness, accuracy or completeness.
Henry McCusker, the editor and publisher of RegMed Investors does not hold or have positions in securities referred to in this publication.